Hepatitis C virus infection: detection and treatment

Matthew L Rubinstein1, Mary E Miele

  • 1Department of Pathology-Virology/Immunology, University Health System, San Antonio, TX, USA.

Insights

Hepatitis C virus (HCV) infection is a significant public health issue. This review covers HCV transmission, diagnosis, current treatments like interferon and ribavirin, and future therapeutic options.

Area of Science:

  • Hepatology
  • Virology
  • Public Health

Background:

  • Hepatitis C virus (HCV) is a blood-borne pathogen impacting millions, leading to severe liver conditions like cirrhosis and cancer.
  • HCV infection represents a critical public health concern in the United States.

Purpose of the Study:

  • To provide a comprehensive review of Hepatitis C virus infection.
  • To discuss transmission, at-risk populations, and clinical manifestations of acute and chronic HCV.
  • To detail diagnostic approaches and current/prospective treatment strategies.

Main Methods:

  • Literature review of Hepatitis C virus transmission, risk groups, and clinical presentations.
  • Description of diagnostic screening and confirmatory tests for HCV.
  • Analysis of current combination therapy (interferon alpha-2b and ribavirin) and future treatments.

Main Results:

  • HCV transmission routes and diverse risk groups are identified.
  • Clinical presentations of acute and chronic HCV infection are outlined.
  • Current treatment efficacy, side effects, and monitoring are discussed, alongside emerging therapies.

Conclusions:

  • Effective diagnosis and management of Hepatitis C virus are crucial for public health.
  • Combination therapy with interferon and ribavirin is a key treatment modality.
  • Ongoing research into novel therapeutics promises improved outcomes for HCV patients.